샘플 요청 목록

 카트 문의
시장보고서
상품코드
1546204

세계의 양성자 치료 시장

Proton Therapy
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 193 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

양성자 치료 세계 시장은 2030년까지 15억 달러에 이를 전망

2023년에 6억 1,460만 달러로 추정되는 양성자 치료 세계 시장은 2023-2030년간 CAGR 13.5%로 성장하여 2030년에는 15억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 가속기는 CAGR13.7%를 나타내고, 분석 기간 종료시에는 8억 4,360만 달러에 이를 것으로 예측됩니다. 빔 딜리버리 시스템 분야의 성장률은 분석 기간에 CAGR 14.2%로 추정됩니다.

미국 시장은 1억 6,560만 달러로 추정, 중국은 CAGR12.5%로 성장 예측

미국 양성자 치료 시장은 2023년에 1억 6,560만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2023-2030년간 CAGR 12.5%로 성장하여, 2030년까지 2억 2,380만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 12.0%와 11.2%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.5%로 성장할 것으로 예측됩니다.

세계 양성자 치료 시장 - 주요 동향 및 촉진요인 요약

암을 정밀하게 표적화하며 성장하는 양성자 치료 시장

양성자 치료는 최첨단 방사선 치료로, 종양을 표적으로 하는 정확하고 효과적인 치료 옵션을 제공함으로써 암 치료의 방식을 바꾸고 있습니다. 주변의 건강한 조직을 손상시킬 수 있는 기존의 X-선 치료와 달리, 양성자 치료는 하전된 입자(양성자)를 사용하여 최대 에너지를 종양 부위에 직접 조사하기 때문에 인접한 건강한 세포에 대한 부수적인 손상을 최소화할 수 있습니다. 이러한 정확성으로 인해 양성자 치료는 뇌, 척추, 눈과 같은 중요한 구조물 근처에 위치하여 기존의 방사선 조사로 심각한 부작용을 유발할 수 있는 종양의 치료에 특히 큰 가치를 발휘합니다. 암 치료의 정확성과 개별화가 점점 더 중요해짐에 따라 양성자 치료는 많은 환자, 특히 소아 및 복잡한 환자들에게 더 나은 치료 옵션으로 인식되고 있습니다.

기술의 발전은 양성자 치료를 어떻게 향상시키고 있는가?

기술의 발전은 양성자 치료의 확대와 개선에 매우 중요한 역할을 하고 있으며, MRI 및 CT 기반 치료 계획과 같은 영상 기술의 혁신은 양성자 조사의 정확도를 크게 향상시켜 임상의가 종양을 더 잘 볼 수 있고 치료 계획을 세울 수 있도록 도와주었습니다. 펜슬 빔 스캐닝(PBS) 기술의 개발은 종양의 정확한 모양에 맞는 고집적 빔을 조사하여 주변 건강한 조직에 대한 선량을 감소시킴으로써 양성자 치료의 정확성을 더욱 향상시켰습니다. 또한, 가속기 기술의 발전으로 치료 시설의 규모와 비용이 줄어들어 양성자 치료의 접근성이 높아졌습니다. 이러한 기술의 발전으로 양성자 치료는 전 세계 암 치료 센터에 보다 현실적이고 매력적인 선택이 되고 있습니다.

확산되는 양성자선 치료의 응용이란?

양자선 치료의 광범위한 암 치료 효과를 뒷받침하는 임상적 근거가 늘어남에 따라 그 적용 범위가 확대되고 있습니다. 양성자 치료는 전통적으로 소아암과 주요 구조물 근처의 종양에 사용되어 왔으며, 현재는 주변 조직에 대한 방사선 피폭을 최소화하는 것이 중요한 유방암, 폐암, 소화기암 치료에도 적용이 검토되고 있습니다. 양성자선 치료는 장기적인 부작용을 줄이고 암 생존자의 삶의 질을 향상시킬 수 있기 때문에 타액선이나 성대 등 중요한 장기에 큰 손상을 줄 수 있는 두경부암 치료에도 적용되고 있습니다. 또한, 현재 진행 중인 연구에서는 면역요법이나 화학요법 등 다른 치료와 병행하여 전반적인 치료 효과를 높일 수 있는 방안도 연구되고 있습니다. 이러한 용도의 확장으로 암 치료에서 양성자선 치료의 범위가 넓어지고 있습니다.

시장 성장의 주요 촉진요인은 무엇인가?

양성자 치료 시장의 성장은 여러 가지 요인에 의해 이루어집니다. 전 세계 암 발병률 증가는 첨단적이고 정확하며 효과적인 치료 옵션에 대한 수요가 지속적으로 증가함에 따라 주요 촉진요인으로 작용하고 있습니다. 이미징, 빔 조사 및 가속기 설계의 기술적 진보로 인해 양성자 치료의 접근성과 유효성이 크게 향상되어 치료 센터에 더욱 매력적인 선택이 되고 있습니다. 양성자 치료로 치료할 수 있는 암의 범위가 넓어지고 그 이점을 뒷받침하는 임상적 근거가 늘어나고 있는 것도 양성자 치료의 채택을 촉진하고 있습니다. 또한, 개인 맞춤형 의료와 정밀의료에 대한 관심이 높아지면서 특히 기존 방사선 치료가 큰 부작용을 유발할 수 있는 경우에 양성자 치료의 사용이 증가하고 있습니다. 전 세계 의료계가 환자 중심 의료에 대한 우선순위를 계속 높여감에 따라 양성자 치료에 대한 수요는 크게 증가할 것으로 예상됩니다.

조사 대상 기업 예(총 43건)

  • Advanced Oncotherapy Plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Mevion Medical Systems, Inc.
  • Mitsubishi Corporation
  • Optivus Proton Therapy, Inc.
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 24.09.10

Global Proton Therapy Market to Reach US$1.5 Billion by 2030

The global market for Proton Therapy estimated at US$614.6 Million in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Accelerators, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$843.6 Million by the end of the analysis period. Growth in the Beam Delivery Systems segment is estimated at 14.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$165.6 Million While China is Forecast to Grow at 12.5% CAGR

The Proton Therapy market in the U.S. is estimated at US$165.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$223.8 Million by the year 2030 trailing a CAGR of 12.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Proton Therapy Market - Key Trends and Drivers Summarized

Targeting Cancer with Precision: The Growing Market for Proton Therapy

Proton therapy is a cutting-edge form of radiation therapy that is transforming the way cancer is treated, offering a highly precise and effective option for targeting tumors. Unlike conventional X-ray radiation, which can damage surrounding healthy tissues, proton therapy uses charged particles (protons) that deliver their maximum energy directly to the tumor site, minimizing collateral damage to adjacent healthy cells. This precision makes proton therapy particularly valuable in treating tumors located near critical structures, such as the brain, spine, and eyes, where conventional radiation could cause significant side effects. As cancer treatment becomes increasingly focused on precision and personalized care, proton therapy is gaining recognition as a superior option for many patients, especially children and those with complex cases.

How Are Technological Advancements Enhancing Proton Therapy?

Technological advancements have played a pivotal role in the expansion and improvement of proton therapy. Innovations in imaging technologies, such as MRI and CT-based planning, have significantly enhanced the accuracy of proton beam delivery, allowing clinicians to better visualize tumors and plan treatments with pinpoint precision. The development of pencil beam scanning (PBS) technology has further improved the precision of proton therapy by enabling the delivery of highly focused beams that can conform to the exact shape of the tumor, reducing the dose to surrounding healthy tissues. Additionally, advancements in accelerator technology have made proton therapy more accessible by reducing the size and cost of treatment facilities. These technological improvements are making proton therapy a more viable and attractive option for cancer treatment centers around the world.

What Are the Expanding Applications of Proton Therapy?

The applications of proton therapy are expanding as more clinical evidence supports its efficacy in treating a wide range of cancers. While traditionally used for pediatric cancers and tumors near critical structures, proton therapy is now being explored for use in treating breast, lung, and gastrointestinal cancers, where minimizing radiation exposure to surrounding tissues is crucial. The potential for proton therapy to reduce long-term side effects and improve the quality of life for cancer survivors is also driving its adoption in the treatment of head and neck cancers, where traditional radiation can cause significant damage to critical organs such as the salivary glands and vocal cords. Additionally, ongoing research is investigating the use of proton therapy in combination with other treatments, such as immunotherapy and chemotherapy, to enhance overall treatment outcomes. These expanding applications are broadening the scope of proton therapy in cancer care.

What Are the Key Growth Drivers in the Market?

The growth in the proton therapy market is driven by several factors. The increasing incidence of cancer worldwide is a major driver, as the demand for advanced, precise, and effective treatment options continues to rise. Technological advancements in imaging, beam delivery, and accelerator design have significantly improved the accessibility and efficacy of proton therapy, making it a more attractive option for treatment centers. The expanding range of cancers that can be treated with proton therapy, coupled with the growing body of clinical evidence supporting its benefits, is also driving adoption. Additionally, the increasing focus on personalized and precision medicine is encouraging the use of proton therapy, particularly in cases where traditional radiation could cause significant side effects. As the global healthcare community continues to prioritize patient-centered care, the demand for proton therapy is expected to grow substantially.

Select Competitors (Total 43 Featured) -

  • Advanced Oncotherapy Plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Mevion Medical Systems, Inc.
  • Mitsubishi Corporation
  • Optivus Proton Therapy, Inc.
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Proton Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer Propels Market Growth
    • Increasing Adoption of Advanced Radiation Therapies Expands Addressable Market Opportunity
    • Technological Advancements in Proton Therapy Systems Strengthen Market Position
    • Growing Focus on Precision Medicine Drives Adoption of Proton Therapy
    • Surge in Demand for Non-Invasive Cancer Treatments Generates New Opportunities
    • Development of Compact and Affordable Proton Therapy Systems Sustains Market Growth
    • Expanding Applications in Pediatric Oncology Throws Spotlight on Market Potential
    • Growth in Global Healthcare Infrastructure Spurs Demand for Proton Therapy
    • Rising Awareness of Proton Therapy's Advantages Over Traditional Radiation Propels Market Expansion
    • Surge in Demand from Emerging Markets Expands Market Horizons
    • Innovations in Image-Guided Proton Therapy Generate New Market Opportunities
    • Increasing Reimbursement Support for Proton Therapy Treatments Accelerates Market Growth
    • Rising Number of Proton Therapy Centers Worldwide Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Proton Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Accelerators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Accelerators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Accelerators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Beam Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Beam Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Beam Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Beam Transport Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Beam Transport Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Beam Transport Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for CNS Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for CNS Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for CNS Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Head & Neck Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Head & Neck Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Head & Neck Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Proton Therapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Proton Therapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Proton Therapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Proton Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제